Publications by authors named "Shinya Ishida"

Claim this Profile
[
[Kidney transplantation for end-stage renal disease after third allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Akihiko Nishijima, Naoki Shingai, Akihito Ohta, Kiyoko Suda, Kazuya Omoto, Shinya Ishida

Rinsho Ketsueki· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Late-onset refractory autoimmune hemolytic anemia following autologous hematologic recovery after allo-HSCT in aplastic anemia-PNH syndrome].
Yuya Kishida, Naoki Shingai, Shinji Nakao, Shinya Ishida, Keita Yamamoto

Rinsho Ketsueki· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.
Hiroki Akiyama, Yoshihiro Umezawa, Daisuke Watanabe, Keigo Okada, Shinya Ishida

Cancers (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.
Hiroki Akiyama, Yoshihiro Umezawa, Shinya Ishida, Keigo Okada, Ayako Nogami

Cancer Lett· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the STAT5/Pim Kinase Axis Enhances Cytotoxic Effects of Proteasome Inhibitors on FLT3-ITD-Positive AML Cells by Cooperatively Inhibiting the mTORC1/4EBP1/S6K/Mcl-1 Pathway.
Ayako Nogami, Keigo Okada, Shinya Ishida, Hiroki Akiyama, Yoshihiro Umezawa

Transl Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2.
Shinya Ishida, Hiroki Akiyama, Yoshihiro Umezawa, Keigo Okada, Ayako Nogami

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway.
Keigo Okada, Ayako Nogami, Shinya Ishida, Hiroki Akiyama, Cheng Chen

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1).
Yoshihiro Umezawa, Hiroki Akiyama, Keigo Okada, Shinya Ishida, Ayako Nogami

J Biol Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report.
Keisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, Shinya Ishida, Toshikage Nagao

Oncol Lett· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Shinya Ishida, Noriko Doki, Naoki Shingai, Kosuke Yoshioka, Kazuhiko Kakihana

Ann Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.
Shuntaro Ikegawa, Noriko Doki, Keita Yamamoto, Naoki Shingai, Yukie Takahashi, Shinya Ishida

Leuk Lymphoma· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic encephalopathy after exposure to azacitidine.
Ken Watanabe, Noriko Doki, Yoshiharu Miura, Takeshi Hagino, Shuhei Kurosawa, Shinya Ishida

Leuk Lymphoma· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Myelofibrosis ameliorated after treatment for nontuberculous mycobacterial infection].
Tatsuya Saito, Keiichiro Hattori, Tomoko Yamashita, Mikako Ueda, Keigo Okada, Shinya Ishida

Rinsho Ketsueki· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recrystallization and reactivation of dopant atoms in ion-implanted silicon nanowires.
Naoki Fukata, Ryo Takiguchi, Shinya Ishida, Shigeki Yokono, Shunichi Hishita

ACS Nano· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral facial nerve palsy caused by a metastatic malignant lymphoma.
Kokoro Ozaki, Takashi Irioka, Shinya Ishida, Hidehiro Mizusawa

Intern Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Segregation behaviors and radial distribution of dopant atoms in silicon nanowires.
Naoki Fukata, Shinya Ishida, Shigeki Yokono, Ryo Takiguchi, Jun Chen

Nano Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duplicate testicular veins accompanied by anomalies of the testicular arteries.
Hao-Gang Xue, Chun-Ying Yang, Shinya Ishida, Kosuke Ishizaka, Akane Ishihara, Asuka Ishida

Ann Anat· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis